About Dr Ben Turner
Consultant Neurologist
Neurology
Sub-specialties: Dizziness, Neuro-ophthalmology, Headache, Multiple Sclerosis, Neurology.
Dr Ben Turner is a highly experienced Consultant Neurologist having practised general neurology for over 20 years and is an Honorary Senior Lecturer for his research work and publications in MS and other neurological conditions.
Bookings: Tel: 
Dr Ben Turner is a highly experienced Consultant Neurologist having practised general neurology for over 20 years and is an Honorary Senior Lecturer for his research work and publications in MS and other neurological conditions.
Areas of Expertise
Dr Ben Turner performs a range of treatments including:
- Botox injection
- Vestibular rehabilitation
- 'GammaCore’ vagal nerve stimulator
- Greater occipital nerve block
- Stem cell therapy for multiple sclerosis
Some of the conditions he commonly treats are:
- Alzheimer's disease
- Huntington’s disease
- Memory disorders
- Motor neurone disease (MND)
- Migraine
- Headache
- Multiple sclerosis (MS)
- Epilepsy
- Brain tumours
- Concussion
- Peripheral neuropathy
- Seizures
- Stroke
- Movement disorders
- Spinal cord tumour
- Spinal disorders
About Dr Ben Turner
Dr Ben Turner is a Consultant Neurologist at OneWelbeck, HSCT lead at Barts Health NHS Trust and a founding member of the London HSCT panel. Thanks to new developments in this field disease suppression is now a realistic option.
Dr Turner trained at St Mary’s Hospital Medical School, University of London, he completed a higher degree of Doctorate of Medicine in MS brain imaging at Nottingham University. At Barts NHS Trust he has been clinical lead, and lead for the Clinical Research Centre which performs clinical trials to develop new medications for neurological conditions, including headache and MS.
Dr Ben Turner provides cutting edge interventions and treatments for headaches and dizziness, including CGRP therapies, Botox and greater occipital nerve blocks. In the MS field, Dr Turner has been directly involved in the clinical research in teriflunomide, dimethyl fumarate, alemtuzumab, cladribine, ocrelizumab, ofatumumab and siponimod.
Research Highlights
Dr Ben Turner has achieved multiple publications in peer-reviewed journals.